newsfilter
← Latest News
GlobeNewswire·

Evelo Biosciences Provides Clinical Updates

– Topline Data from fourth cohort of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint –– Company will focus on development of extracellular vesicles (EVs) –– First EV candidate, EDP2939, in Phase